Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis

Pokaži ostale verzije (1)

<p><b>Background</b></p> Hip and knee replacement surgery is a well‐established means of improving quality of life, but is associated with a significant risk of bleeding. One‐third of people are estimated to be anaemic before hip or knee replacement surgery; coupled with the...

Bibliografski detalji
Glavni autori:	Gibbs, VN, Champaneria, R, Sandercock, J, Welton, NJ, Geneen, LJ, Brunskill, SJ, Dorée, C, Kimber, C, Palmer, AJR, Estcourt, LJ
Format:	Journal article
Jezik:	English
Izdano:	Cochrane Collaboration 2024

Slični predmeti

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a Cochrane systematic review and network meta-analysis
od: Gibbs, V, i dr.
Izdano: (2024)

Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
od: Gibbs, VN, i dr.
Izdano: (2023)

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
od: Estcourt, L, i dr.
Izdano: (2019)

Pharmacological interventions for the treatment of bleeding in people treated for blunt force or penetrating injury in an emergency department: a systematic review and network meta-analysis (Protocol)
od: Erasu, V, i dr.
Izdano: (2022)

The difference in potential harms between whole blood and component blood transfusion in major bleeding: A rapid systematic review and meta-analysis of RCTs
od: Geneen, LJ, i dr.
Izdano: (2021)

Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation of hip, pelvic and long bone fractures: A systematic review and network meta‐analysis
od: Gibbs, V, i dr.
Izdano: (2019)

A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza
od: Kimber, C, i dr.
Izdano: (2022)

Universal irradiation of platelets: does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
od: Cain, L, i dr.
Izdano: (2024)

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis
od: Beverly, A, i dr.
Izdano: (2023)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
od: Geneen, LJ, i dr.
Izdano: (2023)

Network meta-analysis results: pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis
od: Sandercock, J, i dr.
Izdano: (2023)

Competing events and in-hospital follow-up: issues to be aware of
od: Sandercock, J, i dr.
Izdano: (2023)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
od: Huber, J, i dr.
Izdano: (2018)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
od: Butler, C, i dr.
Izdano: (2011)

Pathogen-reduced platelets for the prevention of bleeding.
od: Butler, C, i dr.
Izdano: (2013)

Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used
od: Kohli, R, i dr.
Izdano: (2022)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
od: Estcourt, L, i dr.
Izdano: (2016)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Butler, C, i dr.
Izdano: (2013)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
od: Crighton, GL, i dr.
Izdano: (2021)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
od: Wardrop, D, i dr.
Izdano: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
od: Wardrop, D, i dr.
Izdano: (2013)

Interventions for preventing silent cerebral infarcts in people with sickle cell disease
od: Estcourt, LJ, i dr.
Izdano: (2020)

Systematic review highlights high risk of bias of clinical prediction models for blood transfusion in patients undergoing elective surgery
od: Dhiman, P, i dr.
Izdano: (2023)

Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: A systematic review and network meta analysis
od: Beverly, A, i dr.
Izdano: (2019)

Does bleeding affect patient‐reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review
od: Estcourt, L, i dr.
Izdano: (2014)

Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - a scoping review
od: McCullagh, J, i dr.
Izdano: (2022)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian translation of Cochrane plain language summary)
od: Desborough, MJR, i dr.
Izdano: (2021)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
od: Huber, J, i dr.
Izdano: (2019)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
od: Estcourt, L, i dr.
Izdano: (2015)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Estcourt, L, i dr.
Izdano: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Crighton, GL, i dr.
Izdano: (2015)

Interventions for chronic kidney disease in people with sickle cell disease.
od: Roy, NB, i dr.
Izdano: (2023)

What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis
od: Shah, A, i dr.
Izdano: (2018)

Red cell transfusions for prevention of bleeding: a systematic review and meta-analysis of randomized controlled trials
od: Desborough, M, i dr.
Izdano: (2016)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
od: Huber, J, i dr.
Izdano: (2017)

The role of intra‐operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study
od: Palmer, AJR, i dr.
Izdano: (2020)

Blood management for elective orthopedic surgery
od: Palmer, AJR, i dr.
Izdano: (2020)

Risk of infection associated with administration of intravenous iron: A systematic review and meta-analysis
od: Shah, AA, i dr.
Izdano: (2021)

Utility of pre-operative haemoglobin concentration to guide peri-operative blood tests for hip and knee arthroplasty: a decision curve analysis
od: Dhiman, P, i dr.
Izdano: (2022)

Geographical variation in the provision of elective primary hip and knee replacement: the role of socio-demographic, hospital and distance variables.
od: Judge, A, i dr.
Izdano: (2009)